← Leaderboards
Greg Doyle-Wandell
The Emmes Company, Llc
$13,880,931
Attributed
$13,880,931
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2011–15$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$13,880,931 · 1
By mechanism
N01$13,880,931 · 1
Top collaborators
No co-investigators on record.
Most similar at The Emmes Company, Llc
Same institution · by research overlap
- Ravinder Anand$5,379,842
- Claudine Valmonte$113,656,661
- Peter Russell Dawson$1,402,075
- Robert Lindblad$59,748,609
- Jan Peterson$5,178,528
Others in their field
Top investigators on “Adverse Event”
- James Dennis Neaton · Northwestern University$97,240,825
- Rose A Gubitosi-Klug · Case Western Reserve University$69,866,183
- Lisa P Jacobson · Johns Hopkins University$56,753,115
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$54,912,059
- Robert J Gray · Dana-Farber Cancer Institute$49,428,707
- Susan Abushakra · Alzheon, Inc.$47,690,244
Research focus
Adverse EventAwardBaseBest Pharmaceuticals For Children ActChildChildhoodClinical Practice GuidelineClinical TrialsClinical Trials Data Monitoring CommitteesCommunicationContractsData AnalysesDatabasesData Coordinating CenterData QualityData ReportingDesignDocumentationDrug UsageEnrollmentEnsureEthicsFailure (Biologic Function)Adherence (Attribute)
Grant awards (5)
BEST PHARMACEUTICALS FOR CHILDREN ACT DATA COORDINATING CENTER$1,048,921
N01 · FY2015 · HD · contact PI
BEST PHARMACEUTICALS FOR CHILDREN ACT DATA COORDINATING CENTER$3,590,631
N01 · FY2014 · HD · contact PI
BEST PHARMACEUTICALS FOR CHILDREN ACT DATA COORDINATING CENTER$3,590,631
N01 · FY2013 · HD · contact PI
BEST PHARMACEUTICALS FOR CHILDREN ACT DATA COORDINATING CENTER$4,749,620
N01 · FY2012 · HD · contact PI
BEST PHARMACEUTICALS FOR CHILDREN ACT DATA COORDINATING CENTER$901,128
N01 · FY2011 · HD · contact PI